KCNJ11 activating mutations cause both transient and permanent neonatal diabetes mellitus in Cypriot patients

Pediatric Diabetes

Volumn 12, Issue 2, 2011, Pages 133-137

  Ioannou, Yiannis S ^a   Ellard, Sian ^b   Hattersley, Andrew ^b   Skordis, Nicos ^a  

^a Archbishop Makarios III Hospital   (Cyprus)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

KATP channel; KCNJ11 gene; PNDM; TNDM

Indexed keywords

C PEPTIDE; GENOMIC DNA; GLIBENCLAMIDE; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2;

ARTICLE; CYPRUS; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; FEMALE; GENE MUTATION; HUMAN; HYPERGLYCEMIA; INFANT; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NEWBORN; NEWBORN DIABETES MELLITUS; NEWBORN DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RELAPSE; REMISSION; TREATMENT OUTCOME;

CYPRUS; DIABETES MELLITUS, TYPE 1; DNA MUTATIONAL ANALYSIS; HUMANS; INFANT; MALE; MUTATION; POTASSIUM CHANNELS, INWARDLY RECTIFYING; TIME FACTORS;

EID: 79951975189     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00743.x     Document Type: Article

References (44)

1. Shield JPH, Temple IK. Neonatal diabetes mellitus. Pediatr Diabetes 2002: 3: 109-112.
2. Polak M, Cave H. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Orphanet J Rare Dis 2007: 2: 12.
3. Iafusco D, Stazi MA, Cotichini R, Cotellessa M, Martinucci ME, Mazzella M, Cherubini V, Barbetti F, Martinetti M, Cerutti F, Prisco F. Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology. Permanent diabetes mellitus in the first year of life. Diabetologia 2002: 45: 798-804.
4. Edghill EL, Dix RJ, Flanagan SE et al. HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months. Diabetes 2006: 55: 1895-1898.
5. ATP channel subunits Kir6.2 (KCNJ11) and sulphonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 2009: 30: 170-180.
6. Gloyn AL, Reimann F, Girard C et al. Relapsing diabetes can result from moderately activating mutations in KCNJ11. Hum Mol Genet 2005: 14: 925-934.
7. Temple IK, Gardner RJ, Mackay DJ, Barer JC, Robinson DO, Shield JP. Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes 2000: 49: 1359-1366.
8. Gloyn AL, Pearson ER, Antcliff JF et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004: 350: 1838-1849.
9. Ellard S, Flanagan SE, Girard CA et al. Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet 2007: 81: 375-382.
10. Babenko AP, Polak M, Cave H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire D, Froguel P. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006: 355: 456-466.
11. + channels: a link between b-cell metabolism and insulin secretion. Biochem Soc Trans 1990: 18: 109-111.
12. Koster JC, Permutt A, Nichols CG. Diabetes and insulin secretion. The ATP-sensitive K channel (K ATP) connection. Diabetes 2005: 54: 3065-3072.
13. + channels. Prog Biophys Mol Biol 2003: 81: 133-176.
14. Shyng S, Nichols CG. Octameric stoichiometry of the KATP channel complex. J Gen Physiol 1997: 110: 655-664.
15. Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion J Clin Invest 2005: 115: 2047-2058.
16. Singerland AS, Hattersley AT. Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: new insights and new treatment. Ann Med 2005: 37: 186-189.
17. Pearson ER, Flechtner I, Njølstad PR et al. Neonatal Diabetes International Collaborative Group. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006: 355: 467-77.
18. Tonini G, Bizzarri C, Bonfanti R et al. Early-Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology. Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene. Diabetologia 2006: 49: 2210-2213.
19. Sagen JV, Raeder H, Hathout E et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 2004: 53: 2713-2718.
20. Zung A, Glaser B, Nimri R, Zadik Z. Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J Clin Endocrinol Metab 2004: 89: 5504-5507.
21. Codner E, Flanagan S, Ellard S, García H, Hattersley AT. High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation. Diabetes Care 2005: 28: 758-759.
22. Temple IK, Shield JP. Transient neonatal diabetes, a disorder of imprinting. J Med Genet 2002: 39: 872-875.
23. Cave H, Polak M, Drunat S, Denamur E, Czernichow P. Refinement of the 6q chromosomal region implicated in transient neonatal diabetes. Diabetes 2000: 49: 108-113.
24. + channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 2007: 56: 1930-1937.
25. Koster JC, Remedi MS, Masia R, Patton B, Tong A, Nichols CG. Expression of ATP insensitive K ATP channels in pancreatic β cells underlies a spectrum of diabetic phenotypes. Diabetes 2006: 55: 2957-2964.
26. Proks P, Girard C, Haider S et al. A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome. EMBO Rep 2005: 6: 470-475.
27. Flanagan SE, Edghill EL, Gloyn AL, Ellard S. AT mutations in the KCNJ11 which encodes Kir6.2 are a common cause of diabetes diagnosed in the first 6 months of life with the phenotype determined by genotype. Diabetologia 2006: 49: 1190-1197.
28. Shield JPH, Gardner RJ, Wadsworth EJK et al. Neonatal diabetes: a study of its aetopathology and genetic basis. Arch Dis Child 1997: 76: F39-F49.
29. Slingerland AS, Shields BM, Flanagan SE et al. Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260, 000 live births. Diabetologia 2009: 52: 1683-1685.
30. Colombo C, Delvecchio M, Zecchino C, Faienza MF, Cavallo L, Barbetti F. Early Onset Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology. Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation. Diabetologia 2005: 48: 2439-2441.
31. Klupa T, Edghill EL, Nazim J et al. The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation. Diabetologia 2005: 48: 1029-1031.
32. Dabrowski M, Tarasov A, Ashcroft FM. Mapping the architecture of the ATP-binding site of the KATP channel subunit Kir6.2. J Physiol 2004: 557 (Pt 2): 347-354.
33. Trapp S, Haider S, Jones P, Sansom MS, Ashcroft FM. Identification of residues contributing to the ATP binding site of Kir6.2. EMBO J. 2003: 22: 2903-2912.
34. Gloyn AL, Cummings EA, Edghill EL et al. Permanent neonatal diabetes due to paternal germ line mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel. J Clin Endocrinol Metab 2004: 89: 3932-3935.
35. Edghill EL, Gloyn AL, Goriely A et al. Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings. J Clin Endocrinol Metab 2007: 92: 1773-1777.
36. Suzuki S, Makita Y, Mukai T, Matsuo K, Ueda O, Fujieda K. Basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab 2007: 92: 3979-3985.
37. + channels role of the gamma phosphate group of ATP and the R50 residue of mouse Kir6.2. J Physiol 2005: 568: 931.
38. Proks P, Gribble FM, Adhikari R, Tucker SJ, Ashcroft FM. Involvement of the N' terminus of Kir6.2 in the inhibition of the KATP channel by ATP. J Physiol 1998: 514: 19-25.
39. Flanagan SE, Patch AM, Mackay DJ et al. Mutations in ATP sensitive K channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood diabetes. Diabetes 2007: 56: 1930-1937.
40. Shields BM, Knight B, Shakespeare L et al. Determinants of insulin concentrations in healthy 1-week old babies in the community applications of a bloodspot assay. Early Hum Dev 82: 143.
41. Shimomura K, Girard CA, Proks P et al. Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects. Diabetes 2006: 55: 1705-1712.
42. Proks P, Antcliff JF, Lippiat J, Gloyn AL, Hattersley AT, Ashcroft FM. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc Natl Acad Sci U S A 2004: 101: 17539-17544.
43. Murakami Y, Yamashita Y, Matsuishi T, Utsunomiya H, Okudera T, Hashimoto T. Cranial MRI of neurologically impaired children suffering from neonatal hypoglycemia. Pediatr Radiol 1999: 29: 23-27.
44. Alkalay AL, Flores-Sarnat L, Sarnat HB, Moser FG, Simmons CF. Brain imaging findings in neonatal hypoglycemia: case report and review of 23 cases. Clin Pediatr (Phila) 2005: 44: 783-790.